Jan 11, 2023 / 11:00PM GMT
Ruizhi Qin - JPMorgan Chase & Co, Research Division - Analyst
All right. Let's get started. Good afternoon. Hope everybody's conference is going well so far. I'm Julia Qin, lead analyst covering life science tools and diagnostics at JPMorgan. And it's my great pleasure to introduce you to our next company presentation by NanoString. And without further ado, let me turn it over to Brad. Welcome.
R. Bradley Gray - NanoString Technologies, Inc. - CEO, President & Director
Thank you, Julie. It's great to be here, and thank you all have come out to hear a little bit about NanoString this afternoon. NanoString is a company whose mission is to map the universe of biology. So for the next half hour or so, I'd like to tell you a little bit about the markets we address, primarily spatial biology, the recent progress we've made and our outlook for 2023.
I will be making some forward-looking statements. I will be making use of some non-GAAP financial measures and all of the fiscal year '22 and Q4 numbers are as of now preliminary and unaudited, I refer you
NanoString Technologies Inc at JPMorgan Healthcare Conference Transcript
Feb 08, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers